Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?
about
Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experience.Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102).From basal cell morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots.Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies.Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy
P2860
Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association of adverse events ...... fficacy an impact of toxicity?
@ast
Association of adverse events ...... fficacy an impact of toxicity?
@en
type
label
Association of adverse events ...... fficacy an impact of toxicity?
@ast
Association of adverse events ...... fficacy an impact of toxicity?
@en
prefLabel
Association of adverse events ...... fficacy an impact of toxicity?
@ast
Association of adverse events ...... fficacy an impact of toxicity?
@en
P2093
P1476
Association of adverse events ...... fficacy an impact of toxicity?
@en
P2093
A de Gramont
K Hermunen
L M Soveri
P Österlund
P304
P356
10.1016/J.EJCA.2014.08.017
P50
P577
2014-09-26T00:00:00Z